Showing results (451-460 of 985) with videos related to

Sort By:
Pageof 99
Journal of Pharmaceutical and Biomedical Analysis|August 28, 2007
A generic approach for the determination of residues of alkylating agents in active pharmaceutical ingredients by in situ derivatization-headspace-gas chromatography-mass spectrometryRoberto Alzaga, Robert W Ryan, Karen Taylor-Worth, et al.
Papers in Applied Geography|August 22, 2024
Bigger isn't better: Why small area geographies are best for actionable index developmentWilliam R Buckingham, W Ryan Powell, Sarah Anne Keller, et al.
American Journal of Infection Control|October 17, 2017
Discontinuing contact precautions for multidrug-resistant organisms: A systematic literature review and meta-analysisAlexandre R Marra, Michael B Edmond, Marin L Schweizer, et al.
Nature Communications|October 29, 2014
Evolutionary expansion of a regulatory network by counter-silencingW Ryan Will, Denise H Bale, Philip J Reid, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 1, 1985
Dimethylthiourea consumption reflects H2O2 concentrations and severity of acute lung injuryJ H Jackson, C W White, N B Parker, et al.
Journal of the American Chemical Society|September 27, 2016
Observation of Quantum Confinement in Monodisperse Methylammonium Lead Halide Perovskite Nanocrystals Embedded in Mesoporous SilicaVictor Malgras, Satoshi Tominaka, James W Ryan, et al.
International Journal of Cancer|May 4, 2026
Associations of Outdoor Air Pollution With Incidence of Cancers Other Than Lung Cancer in a Large US Prospective CohortW Ryan Diver, Lauren R Teras, Emily L Deubler, et al.
Investigative Ophthalmology & Visual Science|June 1, 1988
Angiotensin-converting enzyme in bovine, feline, and human ocular tissuesG Ferrari-Dileo, J W Ryan, E J Rockwood, et al.
Journal of the American Society for Mass Spectrometry|March 19, 2017
SITS Derivatization of Peptides to Enhance 266 nm Ultraviolet Photodissociation (UVPD)M Montana Quick, M Rachel Mehaffey, Robert W Johns, et al.
Anti-Cancer Drugs|December 18, 2009
A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapyTomasz M Beer, Charles Ryan, Joshi Alumkal, et al.
Pageof 99